Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee introduces drug‑scheduling updates adding synthetic substances and a new postpartum medication to state schedules
Summary
The Idaho Board of Pharmacy’s update to the Uniform Controlled Substances Act, filed as RS 31822, would add dozens of synthetic drugs to state schedules and place the FDA‑approved postpartum drug zuranolone on Schedule IV, the board’s executive officer told the House Health and Welfare Committee.
Nikki Chopsky, Health Professions Bureau Chief in the Division of Occupational and Professional Licenses and executive officer for the boards of medicine, nursing and pharmacy, presented RS 31822 on behalf of the Idaho Board of Pharmacy.
Chopsky said the bill updates Idaho’s Uniform Controlled Substances Act to add 24 illicit substances (including benzodiazepine derivatives, synthetic fentanyls, synthetic…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
